Scientists identify progenitor cells that could revolutionize osteoarthritis treatment

Researchers report that osteoarthritis is caused by the loss of Gremlin 1 (Grem1)-lineage chondrogenic progenitor cells.

Concussion history in rugby players linked to higher levels of neurodegenerative disease biomarkers

Retired rugby players who have suffered multiple concussions have higher levels of certain proteins in their blood, which may make them more prone to developing

July 17, 2024

Early Interventions for Autism; Imaging After Stenting

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

November 26, 2023

Cerevel failed to draw Pfizer into a bidding war, but got AbbVie to up its price anyway, filing shows

AbbVie’s $45-per-share, $8.7 billion acquisition of the neuroscience drug developer Cerevel Therapeutics was $10 per share higher than its initial bid, according to details in

January 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.